Authors : Angela Devanboo, Dhriti Chendil Nathan, Shweta Kannan Mahalingam, Vishalakshi Apparaya Prabhu, Hema Purandarey, E Venkataswamy, V. L. Ramprasad, Priya Kadam
DOI : 10.18231/j.ijogr.2023.073
Volume : 10
Issue : 3
Year : 2023
Page No : 374-378
Non-invasive prenatal test (NIPT) has become a popular screening test worldwide for screening common trisomies. In addition, the test can also sex chromosomal aneuploidies (SCAs) with similar sensitivity. In recent years, the scope of NIPT has extended to screen pregnancies for clinically significant microdeletions (MDs), rare autosomal aneuploidies, and subchromosomal abnormalities. The clinical utility of NIPT screening beyond trisomies 21,18,13 and SCAs are still being evaluated because of low positive predictive value which in turn leads to an increase in invasive procedures. Here, we present a case where SNP - NIPT correctly identified a microdeletion syndrome, i.e., 22q11.2DS in a pregnant woman with normal ultrasound findings. This NIPT finding was further confirmed in the chromosomal microarray study and FISH.
Keywords: Prenatal screening, SNP -NIPT, Microdeletions, 22q112DS, Chromosomal microarray.